Do patient characteristics matter when calculating sample size for eczema clinical trials?

BACKGROUND: The Patient‐Oriented Eczema Measure (POEM) is the core outcome instrument recommended for measuring patient‐reported atopic eczema symptoms in clinical trials. To ensure that the statistical significance of clinical trial results is meaningful, trials are often designed by specifying the...

Descripción completa

Detalles Bibliográficos
Autores principales: Howells, L., Gran, S., Chalmers, J. R., Stuart, B., Santer, M., Bradshaw, L., Gaunt, D. M., Ridd, M. J., Gerbens, L. A. A., Spuls, P. I., Huang, C., Francis, N. A., Thomas, K. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060078/
https://www.ncbi.nlm.nih.gov/pubmed/35663143
http://dx.doi.org/10.1002/ski2.42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060078/
https://www.ncbi.nlm.nih.gov/pubmed/35663143
http://dx.doi.org/10.1002/ski2.42

Ejemplares similares